ASAAP Malaria Project is rated 3 out of 5 in the category research. Read and write reviews about ASAAP Malaria Project. ASAAP is a 48-month-long multicenter clinical trial research to evaluate the efficacy, safety, tolerability and pharmacokinetics of a new combination of antimalarial drugs, with particular focus on its successful application in one of the largest and most vulnerable demographics of Africa – children under five years of age. ASAAP is coordinated by KCCR in Kumasi - Ghana, under the authority of the Kwame Nkrumah University of Science and Technology (KNUST) with 6 other countries (Gabon, Mali, Benin, Burkina Faso, Germany, and France). Both African and European partners are collaborating on equal terms to achieve maximum success from the planned activities.
Address
South Asuogya, Kumasi
Company size
11-50 employees
Headquarters
Kumasi, Ashanti Region